Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells
出版年份 2013 全文链接
标题
Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells
作者
关键词
-
出版物
Cell Death & Disease
Volume 4, Issue 9, Pages e814
出版商
Springer Nature
发表日期
2013-09-26
DOI
10.1038/cddis.2013.312
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
- (2012) Anurag Singh et al. CELL
- Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1
- (2012) Jie Chen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Downregulation of alpha-fetoprotein expression by LHX4: a critical role in hepatocarcinogenesis
- (2011) Tzu-Min Hung et al. CARCINOGENESIS
- Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer
- (2011) Noriaki Sunaga et al. INTERNATIONAL JOURNAL OF CANCER
- Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma
- (2011) Masashi Yanae et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations
- (2011) Jeeyun Lee et al. JNCI-Journal of the National Cancer Institute
- Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma-Rationale for Comprehensive Mutation Profiling
- (2011) J. E. Chaft et al. MOLECULAR CANCER THERAPEUTICS
- Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
- (2011) N. Sunaga et al. MOLECULAR CANCER THERAPEUTICS
- Berberine Inhibits Human Hepatoma Cell Invasion without Cytotoxicity in Healthy Hepatocytes
- (2011) Bing Liu et al. PLoS One
- Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation
- (2010) Ke Liang et al. CANCER CELL
- Genetic Screen Identifies Insulin-like Growth Factor Binding Protein 5 as a Modulator of Tamoxifen Resistance in Breast Cancer
- (2010) B. Y. Ahn et al. CANCER RESEARCH
- Loss of PTEN Expression by Blocking Nuclear Translocation of EGR1 in Gefitinib-Resistant Lung Cancer Cells Harboring Epidermal Growth Factor Receptor-Activating Mutations
- (2010) C. Yamamoto et al. CANCER RESEARCH
- KRASmutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach
- (2010) Young-Kwang Yoon et al. MOLECULAR CARCINOGENESIS
- Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells
- (2009) Oras Mistafa et al. BIOCHEMICAL PHARMACOLOGY
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
- (2009) Anurag Singh et al. CANCER CELL
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations
- (2009) In Hae Park et al. INVESTIGATIONAL NEW DRUGS
- Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status
- (2008) Catia Cemeus et al. JOURNAL OF NEURO-ONCOLOGY
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now